Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults-Reference-Cited by-同舟云学术

Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults

Published:2016-11-01 Issue:3 Volume:73 Page:294-298
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Gallant Joel,Brunetta Jason,Crofoot Gordon,Benson Paul,Mills Anthony,Brinson Cynthia,Oka Shinichi,Cheng Andrew,Garner Will,Fordyce Marshall,Das Moupali,McCallister Scott,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference17 articles.

1. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel;Huldrych;JAMA,2014

2. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence;Hall;Am J Kidney Dis.,2011

3. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system;Gupta;AIDS Patient Care and STDS.,2008

4. Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, hiv-1-infected adults: 48-week results from the ASSERT Study;Post;J Acquir Immune Defic Syndr.,2010

5. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study;Stellbrink;Clin Infect Dis.,2010

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follow-up and estimation of steatotic liver disease using transient elastography in patients with human immunodeficiency virus;Kanzo;2024-04-01

2. Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study;Clinical Therapeutics;2023-12

3. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial;The Lancet HIV;2023-10

4. Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients;Microbiology Spectrum;2023-06-15

5. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus;Cochrane Database of Systematic Reviews;2023-06-12